Pelthos Therapeutics Inc. insiders: buys and sells · PTHS

Directors, officers and 10%+ shareholders must report every purchase and sale of their company's stock to the SEC within two business days. Transactions filed between 2026-10-02 and 2026-10-02. All filings on SEC EDGAR →

Bought: $0
Sold: $44,939
Buys: 0
Sells: 3

The 3 transactions

Date	Who	Role	Transaction	Shares	Price	Amount
2026-10-02	Greenleaf Peter	Director	sell	797	21,17	$16,872
2026-10-02	Pauls Matthew	Director	sell	786	21,00	$16,506
2026-10-02	Friedberg Ezra M	Director	sell	558	20,717	$11,560

How to read these transactions

There are 3 filed transactions for Pelthos Therapeutics Inc. (PTHS) between 2026-10-02 and 2026-10-02. They were made by 3 different people. Open-market buys: 0, for $0. Sells: 3, for $44,939.

Each transaction comes from a Form 4, the filing the person submits to the SEC. In the table, each row is one transaction: the date, who made it and their role, whether it is a buy or a sell, the number of shares, the declared price per share and the total amount.

Open-market buys are the ones people watch most, because whoever makes them puts in their own money. Sells say less: they often respond to taxes, diversification or sale plans scheduled in advance. A single transaction does not say much either; what people look at is whether they repeat, from how many people and for what amount.

Other companies with insider trades

PELOTON INTERACTIVE, INC. (PTON) · PubMatic, Inc. (PUBM) · PVH CORP. /DE/ (PVH) · PALVELLA THERAPEUTICS, INC. (PVLA) · Phoenix Education Partners, Inc. (PXED) · PayPal Holdings, Inc. (PYPL) · Pyxis Oncology, Inc. (PYXS) · D-Wave Quantum Inc. (QBTS)

Public SEC data (EDGAR), Form 4. Open-market buys and sells only: option exercises and stock received as pay are left out. This is not investment advice.

Follow them next to your own portfolio

In Arvenyx you see these portfolios, insider buys and your own portfolio, across all your brokers, in one place.

Create a free account